Clinical Trial Update: Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating rapamycin (sirolimus)-eluting stents with different polymer coatings to reduce restenosis in coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Heart Disease | Phase 4 | Status: COMPLETED